RecallDepth
Class II Ongoing

Daytrana (methylphenidate transdermal system) CII, 15 mg, 30-count carton, Rx only, Manufactured for Noven Therapeutics, LLC., Miami by Noven Pharmaceuticals, Inc., NDC 68968-5553-3

This recall is currently active, issued March 29, 2023. It was issued by Noven Pharmaceuticals, Inc..

Company
Noven Pharmaceuticals, Inc.
Recall Initiated
March 10, 2023
Posted
March 29, 2023
Recall Number
D-0471-2023
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Miami, FL, United States
Official Source
View on FDA website ↗

Reason for Recall

Defective Delivery System: Out of specification for shear.

Distribution

US Nationwide

Lot / Code Info

Lot#: 91956, Exp. 6/2023; 92475, Exp. 7/2023

More recalls by Noven Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class II Drug recalls